Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
4-( N -( S -glutathionylacetyl)amino)phenylarsonous acid is a prospective cancer drug and has just completed a phase I dose escalation study in patients with solid tumors refractory to standard therapy (Horsley et al., 2013)
Individual response should guide timing decisions
[diabetesjournals.org]
Acknowledgements We would like to thank the contributing researchers, Kafkas University, ankr Karatekin University, Igdir University, and Osh State University
Supermarket pharmacies that use their economies of scale to pass savings onto patients should be encouraged
US$ 28.51
US$ 27.83
US$ 25.55
